Realizing the Promise of Dolutegravir in Effectively Treating Children and Adolescents Living With HIV in Real-world Settings in 6 Countries in Eastern and Southern Africa.
Jason Michael BachaSandile DlaminiFlorence AnabwaniJudith GwimileJacqueline Balungi KanywaJohn FariraiMenard BvumbweMabene TsotakoTeresa SteffyDiane NguyenJose Euberto Mendez-ReyesPeter ElyanuHeather HaqPublished in: The Pediatric infectious disease journal (2023)
We found DTG to be highly effective and safe within our cohort of CALHIV in LMICs. These findings can empower clinicians to prescribe DTG confidently to eligible CALHIV.